SCHEMBL30436447

SCHEMBL30436447

O=C(c1cc(Cc2n[nH]c(=O)c3ccccc23)ccc1F)N1CC(C(=O)N2CCCC2)C1

nearest known ligand 0.82

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 20/20 0.82
PARP3 Q9Y6F1 2/20 0.80
TNKS O95271 1/20 0.80
ADORA1 P30542 1/20 0.80
CDK6 Q00534 1/20 0.80
PDE3A Q14432 1/20 0.80
PARP6 Q2NL67 1/20 0.80
PARP15 Q460N3 1/20 0.80
PARP14 Q460N5 1/20 0.80
PARP10 Q53GL7 1/20 0.80
TIPARP Q7Z3E1 1/20 0.80
PARP8 Q8N3A8 1/20 0.80
PARP16 Q8N5Y8 1/20 0.80
PARP12 Q9H0J9 1/20 0.80
TNKS2 Q9H2K2 1/20 0.80
PARP11 Q9NR21 1/20 0.80
PARP2 Q9UGN5 1/20 0.80
PARP4 Q9UKK3 1/20 0.80

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL16571973 1.00 PARP1 (0.82) PARP1PARP3TNKSADORA1CDK6
SCHEMBL16571972 0.93 PARP1 (0.81) PARP1PARP3TNKSADORA1CDK6
SCHEMBL30331782 0.92 PARP1 (0.84) PARP1PARP3
SCHEMBL19914129 0.92 PARP1 (0.84) PARP1PARP3
SCHEMBL22852727 0.91 PARP1 (0.98) PARP1PARP3TNKSADORA1CDK6
SCHEMBL16571986 0.90 PARP1 (0.77) PARP1PARP3TNKSADORA1CDK6
SCHEMBL16571853 0.89 PARP1 (0.79) PARP1PARP3TNKSADORA1CDK6
Olaparib SCHEMBL426568 0.89 PARP1 (1.00) PARP1PARP3TNKSADORA1CDK6
Olaparib SCHEMBL29392087 0.89 PARP1 (1.00) PARP1PARP3TNKSADORA1CDK6
Olaparib SCHEMBL29352148 0.89 PARP1 (1.00) PARP1PARP3TNKSADORA1CDK6

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3030557-B1 A NOVEL PHTALAZINONE DERIVATIVES AND MANUFACTURING PROCESS THEREOF IDIENCE CO LTD (KR) 2023-05-31 EP disclosed